Cargando…
Multimeric fusion single‐chain variable fragments as potential novel high‐capacity ligands
In basic and applied biotechnology, design of affinity ligands has become essential for high‐capacity applications such as affinity‐based downstream processes for therapeutic molecules. Here, we established a proof‐of‐concept for the use of multimeric fusion single‐chain variable fragment (scFvs) as...
Autores principales: | Sakhnini, Laila I., Pedersen, Anja K., Dainiak, Maria B., Bülow, Leif |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137789/ https://www.ncbi.nlm.nih.gov/pubmed/31950675 http://dx.doi.org/10.1002/2211-5463.12789 |
Ejemplares similares
-
Fusion protein of single-chain variable domain fragments for treatment of myasthenia gravis
por: Li, Fangfang, et al.
Publicado: (2014) -
Construction and function of a fusion protein consisting of a single-chain variable fragment and RBP4
por: Li, Hongxia, et al.
Publicado: (2019) -
Synergistic inhibition of cell-to-cell HIV-1 infection by combinations of single chain variable fragments and fusion inhibitors
por: Alam, Mohammad Mamun, et al.
Publicado: (2019) -
Single-Chain Fragment Variable Passive Immunotherapies for Neurodegenerative Diseases
por: Huang, Liang, et al.
Publicado: (2013) -
Effects of multimerization on the temporal variability of protein complex abundance
por: Häkkinen, Antti, et al.
Publicado: (2013)